Mycopreneur
Sherry Rais: The Enthea Mission
Dec 22, 2023
Sherry Rais, CEO of Enthea, discusses providing psychedelic-assisted therapy as a workplace benefit, global disparities in research, historical perspectives on psychedelics, various access models, and Enthea's expansion into psilocybin therapy.
52:33
Episode guests
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Enthea focuses on making psychedelic-assisted therapy accessible as a workplace benefit for mental health care.
- Collaboration with employers for psychedelic therapy benefits is crucial in overcoming hesitancy and promoting mental health wellness at work.
Deep dives
Enthea's Mission to Provide Psychedelic Assisted Therapy as a Workplace Benefit
Enthea, a third-party administrator of health insurance, focuses on offering psychedelic assisted therapy as a workplace benefit. Their goal is to address the gap in employer-provided mental health care by making psychedelic therapies, starting with ketamine therapy, affordable, accessible, and safe through partnerships with employers. By enhancing employee well-being and productivity, Enthea aims to reduce absenteeism and medical spend while increasing access to psychedelic therapy.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
